These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 37932050)
21. Protocol for a prospective, hospital-based registry of pregnant women with SARS-CoV-2 infection in India: PregCovid Registry study. Gajbhiye RK; Mahajan NN; Waghmare R; Surve SV; Howal P; Bhurke A; Pious M; Modi DN; Mahale SD BMJ Open; 2022 Mar; 12(3):e050039. PubMed ID: 35301200 [TBL] [Abstract][Full Text] [Related]
22. Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review. Huntley BJF; Huntley ES; Di Mascio D; Chen T; Berghella V; Chauhan SP Obstet Gynecol; 2020 Aug; 136(2):303-312. PubMed ID: 32516273 [TBL] [Abstract][Full Text] [Related]
23. Clinical course of coronavirus disease-2019 in pregnancy. Pereira A; Cruz-Melguizo S; Adrien M; Fuentes L; Marin E; Perez-Medina T Acta Obstet Gynecol Scand; 2020 Jul; 99(7):839-847. PubMed ID: 32441332 [TBL] [Abstract][Full Text] [Related]
24. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy. Di Mascio D; Buca D; Berghella V; Khalil A; Rizzo G; Odibo A; Saccone G; Galindo A; Liberati M; D'Antonio F Ultrasound Obstet Gynecol; 2021 May; 57(5):687-697. PubMed ID: 33724545 [TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study. Donati S; Corsi E; Maraschini A; Salvatore MA; BJOG; 2022 Jan; 129(2):221-231. PubMed ID: 34687585 [TBL] [Abstract][Full Text] [Related]
26. A snapshot of the Covid-19 pandemic among pregnant women in France. Kayem G; Lecarpentier E; Deruelle P; Bretelle F; Azria E; Blanc J; Bohec C; Bornes M; Ceccaldi PF; Chalet Y; Chauleur C; Cordier AG; Desbrière R; Doret M; Dreyfus M; Driessen M; Fermaut M; Gallot D; Garabédian C; Huissoud C; Luton D; Morel O; Perrotin F; Picone O; Rozenberg P; Sentilhes L; Sroussi J; Vayssière C; Verspyck E; Vivanti AJ; Winer N; Alessandrini V; Schmitz T J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101826. PubMed ID: 32505805 [TBL] [Abstract][Full Text] [Related]
27. Maternal mortality and COVID-19: A nationwide ecological analysis from Ecuador. Ortiz-Prado E; Izquierdo-Condoy JS; Fernández-Naranjo R; Vásconez-González J; Izquierdo-Condoy N; Checa-Jaramillo D; Yanchapaxi-Silva P; Asmal-Iturralde T; Dávila Rosero MG; Carrington SJ; Sanchez-SanMiguel H Womens Health (Lond); 2024; 20():17455057231219607. PubMed ID: 38553804 [TBL] [Abstract][Full Text] [Related]
28. The severity of COVID-19 among pregnant women and the risk of adverse maternal outcomes. Samadi P; Alipour Z; Ghaedrahmati M; Ahangari R Int J Gynaecol Obstet; 2021 Jul; 154(1):92-99. PubMed ID: 33834499 [TBL] [Abstract][Full Text] [Related]
29. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Gurol-Urganci I; Jardine JE; Carroll F; Draycott T; Dunn G; Fremeaux A; Harris T; Hawdon J; Morris E; Muller P; Waite L; Webster K; van der Meulen J; Khalil A Am J Obstet Gynecol; 2021 Nov; 225(5):522.e1-522.e11. PubMed ID: 34023315 [TBL] [Abstract][Full Text] [Related]
30. Clinical Stratification of Pregnant COVID-19 Patients based on Severity: A Single Academic Center Experience. Berry M; Wang A; Clark SM; Harirah HM; Jain S; Olson GL; Pacheco LD; Saade GR; Saad AF Am J Perinatol; 2021 Apr; 38(5):515-522. PubMed ID: 33548937 [TBL] [Abstract][Full Text] [Related]
31. Maternal and neonatal outcomes of COVID-19 in a high-risk pregnant cohort with and without HIV. De Waard L; Langenegger E; Erasmus K; Van der Merwe T; Olivier SE; Du Toit N; Paulsen C; Nkangana N; Van Niekerk M; Moodley A; Schell S; Taljaard J; Botha MH; Dramowski A; Cluver CA; Bekker A S Afr Med J; 2021 Dec; 111(12):1174-1180. PubMed ID: 34949304 [TBL] [Abstract][Full Text] [Related]
32. COVID-19 in pregnant women: A systematic review and meta-analysis. Capobianco G; Saderi L; Aliberti S; Mondoni M; Piana A; Dessole F; Dessole M; Cherchi PL; Dessole S; Sotgiu G Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():543-558. PubMed ID: 32713730 [TBL] [Abstract][Full Text] [Related]
33. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak. Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837 [TBL] [Abstract][Full Text] [Related]
34. Association of D-Dimer, C-Reactive Protein, and Ferritin with COVID-19 Severity in Pregnant Women: Important Findings of a Cross-Sectional Study in Northern Brazil. Paixão JTR; Santos CJSE; França APFM; Lima SS; Laurentino RV; Fonseca RRS; Vallinoto ACR; Oliveira-Filho AB; Machado LFA Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510647 [TBL] [Abstract][Full Text] [Related]
35. An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women. Kalafat E; Prasad S; Birol P; Tekin AB; Kunt A; Di Fabrizio C; Alatas C; Celik E; Bagci H; Binder J; Le Doare K; Magee LA; Mutlu MA; Yassa M; Tug N; Sahin O; Krokos P; O'brien P; von Dadelszen P; Palmrich P; Papaioannou G; Ayaz R; Ladhani SN; Kalantaridou S; Mihmanli V; Khalil A Am J Obstet Gynecol; 2022 Mar; 226(3):403.e1-403.e13. PubMed ID: 34582796 [TBL] [Abstract][Full Text] [Related]
37. The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey. Tanacan A; Erol SA; Turgay B; Anuk AT; Secen EI; Yegin GF; Ozyer S; Kirca F; Dinc B; Unlu S; Yapar Eyi EG; Keskin HL; Sahin D; Surel AA; Tekin OM Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():31-34. PubMed ID: 32763728 [TBL] [Abstract][Full Text] [Related]
38. Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19. Torres-Torres J; Espino-Y-Sosa S; Poon LC; Solis-Paredes JM; Estrada-Gutierrez G; Espejel-Nuñez A; Juarez-Reyes A; Etchegaray-Solana A; Alfonso-Guillen Y; Aguilar-Andrade L; Hernández-Pacheco JA; Villafan-Bernal JR; Martinez-Portilla RJ Ultrasound Obstet Gynecol; 2022 Feb; 59(2):202-208. PubMed ID: 34664753 [TBL] [Abstract][Full Text] [Related]
39. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial. Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ Trials; 2021 May; 22(1):342. PubMed ID: 34001174 [TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of SARS-CoV-2 virus antibodies and sociodemographic features of pregnant women in Mogadishu, Somalia: a cross-sectional survey study. Sh Nur MA; Dahie HA; Hassan NA; Garba B; Adam MHA; Mohamoud JH; Dirie NI BMJ Open; 2022 Jun; 12(6):e059617. PubMed ID: 35680266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]